Top Markets
Coin of the day
Wuhan YZY Biopharma Co Ltd Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltd

2496
Classifica tra le azioni #22213
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the... Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various solid tumors (including pancreatic cancer, hepatocellular carcinoma, other advanced solid tumors, and HER2-positive solid tumors), small cell lung cancer, and relapsed/refractory multiple myeloma. Additionally, they are advancing therapies for COVID-19 and several eye disorders like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and other conditions characterized by abnormal blood vessel formation in the eye. The company, established in 2010, is headquartered in Wuhan, China.
Prezzo delle azioni
$0.46053443
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$92.44M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-36.86%
Paese
CN
Scambia Wuhan YZY Biopharma Co Ltd (2496)

Categoria

Storico del prezzo dell'azione per Wuhan YZY Biopharma Co Ltd (2496)
Prezzo di chiusura più alto: $0.46 il 2026-08-01

Prezzo di chiusura più basso: $2.19 il 2023-09-01
Storico del prezzo dell'azione di Wuhan YZY Biopharma Co Ltd dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -17.33%
2025 56.85%
2024 -47.06%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH